Angiostatin production increases in response to decreased nitric oxide in aging rat kidney

Laboratory Investigation

Volumn 93, Issue 3, 2013, Pages 334-343

  Satoh, Minoru ^a   Kidokoro, Kengo ^a   Ozeki, Masahito ^a   Nagasu, Hajime ^a   Nishi, Yuko ^a   Ihoriya, Chieko ^a   Fujimoto, Sohachi ^a   Sasaki, Tamaki ^a   Kashihara, Naoki ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

aging; angiostatin; cathepsin D; nitric oxide

Indexed keywords

ANGIOSTATIN; CATHEPSIN D; MOLSIDOMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VIVO STUDY; KIDNEY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84874620047     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.171     Document Type: Article

References (36)

1. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147
2. Abdelhafiz AH, Brown SH, Bello A, et al. Chronic kidney disease in older people: Physiology, pathology or both? Nephron Clin Pract 2010;116:c19-c24
3. Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol 2000;11:47-56
4. Choi YJ, Chakraborty S, Nguyen V, et al. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: Altered expression of vascular endothelial growth factor. Hum Pathol 2000;31:1491-1497
5. Yuan HT, Li XZ, Pitera JE, et al. Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha. Am J Pathol 2003;163:2289-2301
6. Thomas SE, Anderson S, Gordon KL, et al. Tubulointerstitial disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 1998;9:231-242
7. Kang DH, Anderson S, Kim YG, et al. Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 2001;37:601-611
8. Satoh M, Fujimoto S, Horike H, et al. Mitochondrial damage-induced impairment of angiogenesis in the aging rat kidney. Lab Invest 2011;91:190-202
9. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328
10. Soff GA. Angiostatin and angiostatin-related proteins. Cancer Metastasis Rev 2000;19:97-107
11. Basile DP, Fredrich K, Weihrauch D, et al. Angiostatin and matrix metalloprotease expression following ischemic acute renal failure. Am J Physiol Renal Physiol 2004;286:F893-F902
12. Zhang SX, Wang JJ, Lu K, et al. Therapeutic potential of angiostatin in diabetic nephropathy. J Am Soc Nephrol 2006;17:475-486
13. Ziche M, Morbidelli L. Nitric oxide and angiogenesis. J Neurooncol 2000;50:139-148
14. Cooke JP, Losordo DW. Nitric oxide and angiogenesis. Circulation 2002;105:2133-2135
15. Wever R, Boer P, Hijmering M, et al. Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 1999;19:1168-1172
16. Hill C, Lateef AM, Engels K, et al. Basal and stimulated nitric oxide in control of kidney function in the aging rat. Am J Physiol 1997;272:R1747-R1753
17. Reckelhoff JF, Kellum JA, Blanchard EJ, et al. Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging. Life Sci 1994;55:1895-1902
18. Tank JE, Vora JP, Houghton DC, et al. Altered renal vascular responses in the aging rat kidney. Am J Physiol 1994;266:F942-F948
19. Ridnour LA, Isenberg JS, Espey MG, et al. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci USA 2005;102:13147-13152
20. Matsunaga T, Weihrauch DW, Moniz MC, et al. Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 2002;105:2185-2191
21. Bongartz LG, Braam B, Verhaar MC, et al. The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction. Am J Physiol Heart Circ Physiol 2010;299:H2037-H2045
22. Tojo A, Kimoto M, Wilcox CS. Renal expression of constitutive NOS and DDAH: Separate effects of salt intake and angiotensin. Kidney Int 2000;58:2075-2083
23. Morikawa W, Yamamoto K, Ishikawa S, et al. Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells. J Biol Chem 2000;275:38912-38920
24. Cornelius LA, Nehring LC, Harding E, et al. Matrix metalloproteinases generate angiostatin: Effects on neovascularization. J Immunol 1998;161:6845-6852
25. Mu W, Long DA, Ouyang X, et al. Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism. Am J Physiol Renal Physiol 2009;296:F145-F152
26. Erdely A, Greenfeld Z, Wagner L, et al. Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system. Kidney Int 2003;63:1021-1026
27. Adler S, Huang H, Wolin MS, et al. Oxidant stress leads to impaired regulation of renal cortical oxygen consumption by nitric oxide in the aging kidney. J Am Soc Nephrol 2004;15:52-60
28. Baylis C. Sexual dimorphism in the aging kidney: Differences in the nitric oxide system. Nat Rev Nephrol 2009;5:384-396
29. Graciano ML, Cavaglieri Rde C, Delle H, et al. Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 2004;15:1805-1815
30. Wang F, Duan R, Chirgwin J, et al. Transcriptional activation of cathepsin D gene expression by growth factors. J Mol Endocrinol 2000;24:193-202
31. Cho JH, Park IY, Kim MS, et al. Matrix metalloproteinase 2 is involved in the regulation of the antimicrobial peptide parasin I production in catfish skin mucosa. FEBS Lett 2002;531:459-463
32. Chen HH, Wang DL. Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells. Mol Pharmacol 2004;65:1130-1140
33. Perchick GB, Jabbour HN. Cyclooxygenase-2 overexpression inhibits cathepsin D-mediated cleavage of plasminogen to the potent antiangiogenic factor angiostatin. Endocrinology 2003;144:5322-5328
34. Patterson BC, Sang QA. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 1997;272:28823-28825
35. O'Reilly MS, Wiederschain D, Stetler-Stevenson WG, et al. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem 1999;274:29568-29571
36. Maeshima Y, Makino H. Angiogenesis and chronic kidney disease. Fibrogenesis Tissue Repair 2010;3:13